Deparmtent of Clinical Neuropsychology, University Hospitals Birmingham NHS Foundation Trust, United Kingdom of Great Britain and Northern Ireland.
School of Applied Psychology, Edgbaston Campus, University of Birmingham, Birmingham, United Kingdom of Great Britain and Northern Ireland.
Appl Neuropsychol Adult. 2022 Sep-Oct;29(5):1103-1111. doi: 10.1080/23279095.2020.1852237. Epub 2020 Dec 7.
This study cross-validates the screening module of the Neuropsychological Assessment Battery (NAB-SM) with a battery of well validated neuropsychological tests (Convergent Validity Test Battery: CVTB) in a Traumatic Brain Injury (TBI) population. Forty-four participants with "mild-complicated" to "severe" TBI were recruited from a cohort of patients attending an outpatient clinic at a UK major trauma center. The NAB-SM Total Index score and an abbreviated short-form, from which a TBI Index was derived, both showed good classification accuracy in predicting impairment as measured by the CVTB mean score. These indices also accurately identified impairment as defined by the base rate of low scores across individual CVTB indices measuring mental processing speed, working memory, memory and executive functioning. The NAB-SM and its derived TBI index therefore have significant utility as a cognitive screening tool for use in either inpatient (acute) or outpatient TBI populations.
本研究通过对一系列经过充分验证的神经心理学测试（Convergent Validity Test Battery，CVTB）对神经心理评估电池（Neuropsychological Assessment Battery，NAB）的筛查模块进行了交叉验证，该研究对象为创伤性脑损伤（Traumatic Brain Injury，TBI）人群。44 名“轻度复杂”至“重度”TBI 患者从英国一家大型创伤中心的门诊患者队列中招募。NAB-SM 总指数评分和一个简化的短式版本，从中得出了 TBI 指数，这两个指数在预测 CVTB 平均评分测量的认知障碍方面都显示出了良好的分类准确性。这些指数还准确地识别了个别 CVTB 指数衡量的心理加工速度、工作记忆、记忆和执行功能的低分数的基础比率所定义的认知障碍。因此，NAB-SM 及其衍生的 TBI 指数可作为认知筛查工具，用于住院（急性）或门诊 TBI 患者群体。
